Creon DR 36,000 unit capsule UU 100S
Ended Awarded
- Contract number
- SPE2DR26FHY5T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $77,596
Award facts
- Contract value 100% obligated
- $77,595.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $77,595.73 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules. This non-competitive delivery order, issued on November 3, 2025, represents a firm fixed price procurement with a completion date of November 4, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract is classified as a child order under a larger contract vehicle, enabling the rapid procurement of this pharmaceutical supply to support federal healthcare operations.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs. Creon DR is a pancreatic enzyme replacement therapy commonly used to support digestive function in patients with pancreatic insufficiency. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp has demonstrated consistent capability in fulfilling federal medical procurement requirements through open competition across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies supporting the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FHY5T?
SPE2DR26FHY5T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FHY5T worth?
The government has obligated $77,596 on SPE2DR26FHY5T.
Is contract SPE2DR26FHY5T an order under another contract?
Yes. SPE2DR26FHY5T is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FHY5T competed?
The extent of competition for SPE2DR26FHY5T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award